News

September 8, 2017September 8, 2017

miRagen Therapeutics to Present New Promising Data on MRG-201 at ERS 2017

miRagen Therapeutics, a biopharmaceutical company involved in the discovery of RNA-based therapies, will present new preclinical safety and feasibility data for the therapy MRG-201 in the treatment of pulmonary fibrosis at the ... Read more

September 7, 2017September 7, 2017

Working Lung Model with Intact Vasculature Likely to Aid Research, Lung Transplants

Idiopathic Pulmonary Fibrosis, News

Researchers at Columbia University have found a way to bioengineer a “working” lung — a very complex structure — with a viable and intact blood vessel network that can support studies of ... Read more

September 6, 2017September 6, 2017

Smoking Could Influence IPF Progression, But More Research Is Needed

Idiopathic Pulmonary Fibrosis, News

A new study reported that smoking might influence the course of progression in IPF patients, although further investigation is needed to better understand this association. Previous research has shown that cigarette smoking ... Read more

September 1, 2017September 1, 2017

Asthma Is Associated with Subsequent Development of Inflammatory Bowel Disease, Study Shows

Asthma, News

A population-based study found an association between asthma and the subsequent development of inflammatory bowel disease (IBD). Using health databases from Alberta, Canada, the study examined 5,464 IBD patients (3,087 with Crohn’s disease ... Read more

August 31, 2017August 31, 2017

Protein Linked to Fibrosis Progression Will Be Focus of Start-up’s Drive for Anti-fibrotic Therapy

Idiopathic Pulmonary Fibrosis, News

Researchers in Singapore have found that inhibiting a protein called interleukin-11, or IL-11, can block fibrosis progression in mice. Enleofen Bio, a recently founded biotechnology start-up company, will try to move this finding ... Read more

August 30, 2017August 30, 2017

British Researchers Study Why Asthmatic Kids are More Likely to be Overweight

Asthma, News

Children with asthma are more likely to be overweight, and obesity, in turn, often makes asthma more severe. To find out why, researchers at two British institutions have launched a project ... Read more

August 29, 2017August 29, 2017

Three Share British Lung Foundation Grant for Lung Disease Research

Bronchiectasis, COPD, Idiopathic Pulmonary Fibrosis, News

Toby Maher, MD, a professor at Imperial College London and based at the National Heart and Lung Institute, is one of three researchers who were awarded the prestigious Chair in Respiratory Research grant ... Read more

August 28, 2017August 28, 2017

PharmAkea Completes Phase 1 Clinical Trial of Pulmonary Fibrosis Therapy PAT-1251

Idiopathic Pulmonary Fibrosis, News

PharmaAkea has completed a Phase 1 clinical trial indicating that its PAT-1251 therapy binds with an enzyme associated with pulmonary fibrosis. That suggests that it could be an effective treatment for ... Read more

August 25, 2017August 25, 2017

E-Cigarettes Carry Much Less Risk of Lung Cancer Than Cigarette Smoke, Study Finds

Lung Cancer, News

E-cigarettes carry much less cancer risk than tobacco smoke, although some types are more risky than others, a study shows. The research, “Comparing the cancer potencies of emissions from vapourised ... Read more

August 24, 2017August 25, 2017

Ethris, AstraZeneca and MedImmune to Collaborate on Developing Respiratory Disease Therapies

Asthma, COPD, Idiopathic Pulmonary Fibrosis, News

Ethris has entered into a five-year research partnership with AstraZeneca and its subsidiary MedImmune to develop mRNA-based therapies for lung diseases. The partnership will use Ethris’ proprietary SNIM®RNA technology. The nucleic acid ... Read more